Sign in
4

Changes in Ownership

4D Molecular Therapeutics, Inc. Filed Acc 0001193125-25-238995

Chief Legal Officer sold 2,408 shares at $10.00 ($24,080)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Bizily Scott · Chief Legal Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-10-09 Sale : show line 1 in the form 10b5-1 −2,408 $10.00 $24,080 5,188 D
Open-market sales · 2,408 sh · avg $10.00 · $24,080
Loading xslF345X05/ownership.xml…